ENTRY       K05429                      KO
NAME        IL2
DEFINITION  interleukin 2
PATHWAY     ko04060  Cytokine-cytokine receptor interaction
            ko04151  PI3K-Akt signaling pathway
            ko04630  Jak-STAT signaling pathway
            ko04660  T cell receptor signaling pathway
            ko04672  Intestinal immune network for IgA production
            ko04940  Type I diabetes mellitus
            ko05142  Chagas disease (American trypanosomiasis)
            ko05162  Measles
            ko05166  HTLV-I infection
            ko05320  Autoimmune thyroid disease
            ko05321  Inflammatory bowel disease (IBD)
            ko05330  Allograft rejection
            ko05332  Graft-versus-host disease
DISEASE     H00084  Graft-versus-host disease
            H00408  Type I diabetes mellitus
BRITE       KEGG Orthology (KO) [BR:ko00001]
             Environmental Information Processing
              Signal transduction
               04630 Jak-STAT signaling pathway
                K05429  IL2; interleukin 2
               04151 PI3K-Akt signaling pathway
                K05429  IL2; interleukin 2
              Signaling molecules and interaction
               04060 Cytokine-cytokine receptor interaction
                K05429  IL2; interleukin 2
             Organismal Systems
              Immune system
               04660 T cell receptor signaling pathway
                K05429  IL2; interleukin 2
               04672 Intestinal immune network for IgA production
                K05429  IL2; interleukin 2
             Human Diseases
              Immune diseases
               05320 Autoimmune thyroid disease
                K05429  IL2; interleukin 2
               05321 Inflammatiory bowel disease (IBD)
                K05429  IL2; interleukin 2
               05330 Allograft rejection
                K05429  IL2; interleukin 2
               05332 Graft-versus-host disease
                K05429  IL2; interleukin 2
              Endocrine and metabolic diseases
               04940 Type I diabetes mellitus
                K05429  IL2; interleukin 2
              Infectious diseases
               05166 HTLV-I infection
                K05429  IL2; interleukin 2
               05162 Measles
                K05429  IL2; interleukin 2
               05142 Chagas disease (American trypanosomiasis)
                K05429  IL2; interleukin 2
            Cytokines [BR:ko04052]
             Class I cytokines (hematopoietin family)
              IL-2 receptor family
               K05429  IL2; interleukin 2
            Heparan sulfate/heparin binding proteins [BR:ko00536]
             Cytokines
              K05429  IL2; interleukin 2
DBLINKS     GO: 0005134
GENES       HSA: 3558(IL2)
            PTR: 461472(IL2)
            PPS: 100984780(IL2)
            GGO: 101132394(IL2)
            PON: 100455248(IL2)
            MCC: 708017(IL2)
            MCF: 102129830(IL2)
            MMU: 16183(Il2)
            RNO: 116562(Il2)
            CGE: 100755773(Il2)
            HGL: 101720581(Il2)
            TUP: 102478615(IL2)
            CFA: 403989(IL2)
            AML: 100480862(IL2)
            FCA: 751114(IL2)
            PTG: 102957506(IL2)
            BTA: 280822(IL2)
            BOM: 102272426(IL2)
            PHD: 102322091(IL2)
            CHX: 102183089(IL2)
            SSC: 396868(IL2)
            CFR: 102514894(IL2)
            BACU: 103017896(IL2)
            LVE: 103071508(IL2)
            ECB: 100034204(IL2)
            MYB: 102246940(IL2)
            MYD: 102773629(IL2)
            PALE: 102895516(IL2)
            MDO: 100619184(IL2)
            SHR: 100935068(IL2)
            GGA: 373958(IL2)
            MGP: 100303688(IL2)
            FAB: 101807567(IL2)
            APLA: 101794925(IL-2)
            CLV: 102091580
REFERENCE   PMID:21889323
  AUTHORS   Liao W, Lin JX, Leonard WJ
  TITLE     IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation.
  JOURNAL   Curr Opin Immunol 23:598-604 (2011)
///
